Larimar Therapeutics, Inc.
LRMRNASDAQ
Healthcare
Biotechnology
$4.91
+0.12(2.4%)
52W $1.71 – $5.95
Quick:
10-K
Mar 19, 2026 (2 weeks ago)Annual Report
Full-year financial statements and risk factors
YoY revenue/margin trends, new risk disclosures
8-K
Mar 19, 2026 (2 weeks ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Mar 9, 2026 (4 weeks ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Feb 27, 2026 (1 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Feb 24, 2026 (1 months ago)Current Report
Material event disclosure
Event materiality and market reaction
SCHEDULE 13G/A
Feb 17, 2026 (1 months ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active
SCHEDULE 13G/A
Feb 12, 2026 (1 months ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active
8-K
Jan 22, 2026 (2 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Jan 12, 2026 (2 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Dec 17, 2025 (3 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Nov 10, 2025 (4 months ago)Current Report
Material event disclosure
Event materiality and market reaction
SCHEDULE 13G/A
Nov 6, 2025 (5 months ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active
8-K
Nov 5, 2025 (5 months ago)Current Report
Material event disclosure
Event materiality and market reaction
10-Q
Nov 5, 2025 (5 months ago)Quarterly Report
Quarterly financial update
Sequential growth, guidance changes
8-K
Oct 14, 2025 (5 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Sep 29, 2025 (6 months ago)Current Report
Material event disclosure
Event materiality and market reaction
SCHEDULE 13G
Aug 29, 2025 (7 months ago)Beneficial Ownership
Large shareholder position disclosure
Ownership threshold, passive vs active
10-Q
Aug 14, 2025 (7 months ago)Quarterly Report
Quarterly financial update
Sequential growth, guidance changes
8-K
Aug 14, 2025 (7 months ago)Current Report
Material event disclosure
Event materiality and market reaction
SCHEDULE 13G/A
Aug 14, 2025 (7 months ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active